These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28155596)

  • 1. Inhibition of Tau Protein Aggregation by Rhodanine-based Compounds Solubilized Via Specific Formulation Additives to Improve Bioavailability and Cell Viability.
    Pickhardt M; Lawatscheck C; Borner HG; Mandelkow E
    Curr Alzheimer Res; 2017; 14(7):742-752. PubMed ID: 28155596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the way to precision formulation additives: 2D-screening to select solubilizers with tailored host and release capabilities.
    Remmler D; Schwaar T; Pickhardt M; Donth C; Mandelkow E; Weller MG; Börner HG
    J Control Release; 2018 Sep; 285():96-105. PubMed ID: 29964137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural determinants of Tau aggregation inhibitor potency.
    Schafer KN; Cisek K; Huseby CJ; Chang E; Kuret J
    J Biol Chem; 2013 Nov; 288(45):32599-32611. PubMed ID: 24072703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalizing the Concept of Specific Compound Formulation Additives towards Non-Fluorescent Drugs: A Solubilization Study on Potential Anti-Alzheimer-Active Small-Molecule Compounds.
    Lawatscheck C; Pickhardt M; Wieczorek S; Grafmüller A; Mandelkow E; Börner HG
    Angew Chem Int Ed Engl; 2016 Jul; 55(30):8752-6. PubMed ID: 27282127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cells.
    Pickhardt M; Larbig G; Khlistunova I; Coksezen A; Meyer B; Mandelkow EM; Schmidt B; Mandelkow E
    Biochemistry; 2007 Sep; 46(35):10016-23. PubMed ID: 17685560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau overexpression inhibits cell apoptosis with the mechanisms involving multiple viability-related factors.
    Wang HH; Li HL; Liu R; Zhang Y; Liao K; Wang Q; Wang JZ; Liu SJ
    J Alzheimers Dis; 2010; 21(1):167-79. PubMed ID: 20413892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of tau aggregation in cell models of tauopathy.
    Khlistunova I; Pickhardt M; Biernat J; Wang Y; Mandelkow EM; Mandelkow E
    Curr Alzheimer Res; 2007 Dec; 4(5):544-6. PubMed ID: 18220518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PE859, A Novel Curcumin Derivative, Inhibits Amyloid-β and Tau Aggregation, and Ameliorates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8.
    Okuda M; Fujita Y; Hijikuro I; Wada M; Uemura T; Kobayashi Y; Waku T; Tanaka N; Nishimoto T; Izumi Y; Kume T; Akaike A; Takahashi T; Sugimoto H
    J Alzheimers Dis; 2017; 59(1):313-328. PubMed ID: 28598836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs.
    Khlistunova I; Biernat J; Wang Y; Pickhardt M; von Bergen M; Gazova Z; Mandelkow E; Mandelkow EM
    J Biol Chem; 2006 Jan; 281(2):1205-14. PubMed ID: 16246844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent Tau Aggregation Inhibitor D-Peptides Selected against Tau-Repeat 2 Using Mirror Image Phage Display.
    Malhis M; Kaniyappan S; Aillaud I; Chandupatla RR; Ramirez LM; Zweckstetter M; Horn AHC; Mandelkow E; Sticht H; Funke SA
    Chembiochem; 2021 Nov; 22(21):3049-3059. PubMed ID: 34375027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model.
    Wang YP; Biernat J; Pickhardt M; Mandelkow E; Mandelkow EM
    Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10252-7. PubMed ID: 17535890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compound screening in cell-based models of tau inclusion formation: Comparison of primary neuron and HEK293 cell assays.
    Crowe A; Henderson MJ; Anderson J; Titus SA; Zakharov A; Simeonov A; Buist A; Delay C; Moechars D; Trojanowski JQ; Lee VM; Brunden KR
    J Biol Chem; 2020 Mar; 295(12):4001-4013. PubMed ID: 32034092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent rhodanine-3-acetic acids visualize neurofibrillary tangles in Alzheimer's disease brains.
    Anumala UR; Gu J; Lo Monte F; Kramer T; Heyny-von Haußen R; Hölzer J; Goetschy-Meyer V; Schön C; Mall G; Hilger I; Czech C; Herms J; Schmidt B
    Bioorg Med Chem; 2013 Sep; 21(17):5139-44. PubMed ID: 23859773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau peptides and tau mutant protein aggregation inhibition by cationic polyethyleneimine and polyarginine.
    Nadimidla K; Ismail T; Kanapathipillai M
    Biopolymers; 2017 Sep; 107(9):. PubMed ID: 28456996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau Fragment.
    Pir GJ; Choudhary B; Kaniyappan S; Chandupatla RR; Mandelkow E; Mandelkow EM; Wang Y
    Mol Neurobiol; 2019 May; 56(5):3751-3767. PubMed ID: 30196394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for Tauopathies.
    Pickhardt M; Neumann T; Schwizer D; Callaway K; Vendruscolo M; Schenk D; St George-Hyslop P; Mandelkow EM; Dobson CM; McConlogue L; Mandelkow E; Tóth G
    Curr Alzheimer Res; 2015; 12(9):814-28. PubMed ID: 26510979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cobalt-based metal complexes prevent Repeat Tau aggregation and nontoxic to neuronal cells.
    Gorantla NV; Balaraman E; Chinnathambi S
    Int J Biol Macromol; 2020 Jun; 152():171-179. PubMed ID: 32105696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper binding properties of a tau peptide associated with Alzheimer's disease studied by CD, NMR, and MALDI-TOF MS.
    Ma Q; Li Y; Du J; Liu H; Kanazawa K; Nemoto T; Nakanishi H; Zhao Y
    Peptides; 2006 Apr; 27(4):841-9. PubMed ID: 16225961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhodanine-based tau aggregation inhibitors in cell models of tauopathy.
    Bulic B; Pickhardt M; Khlistunova I; Biernat J; Mandelkow EM; Mandelkow E; Waldmann H
    Angew Chem Int Ed Engl; 2007; 46(48):9215-9. PubMed ID: 17985339
    [No Abstract]   [Full Text] [Related]  

  • 20. Syringic acid demonstrates promising protective effect against tau fibrillization and cytotoxicity through regulation of endoplasmic reticulum stress-mediated pathway as a prelude to Alzheimer's disease.
    Li X; Zhang X; Xing R; Qi F; Dong J; Li D; Tian X; Yu B; Huang M; Zhang L; Yuan X; Yang Y; Wu H; Zang L; Mao X; Sui R
    Int J Biol Macromol; 2021 Dec; 192():491-497. PubMed ID: 34599991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.